Novavax Names Jeffrey Church Chief Financial Officer

21-Aug-2006

Novavax, Inc. said that Jeffrey Church has been appointed Vice President, Chief Financial Officer and Treasurer, effective September 5, 2006. Mr. Church joins Novavax from GenVec, Inc., where he served as CFO, Treasurer and Corporate Secretary since 1988. During his tenure at GenVec, Mr. Church raised approximately $150 million in debt and equity financing.

A certified public accountant, Mr. Church was an Executive Vice President, CFO and Director of Biospherics Inc., now known as Spherix, where he directed a team of 250 professionals in sales and marketing, technical services and financial functions. Prior to Biospherics, Mr. Church served as Senior Vice President and CFO of the device concern Meridian Medical Technologies Inc. Mr. Church helped in transforming Meridian from an unprofitable defense contractor to a profitable medical device company that, subsequently, was acquired by King Pharmaceuticals for $247 million.

A summa cum laude graduate of the University of Maryland, Mr. Church began his career as an audit manager in the Baltimore, Maryland, office of Price Waterhouse.

https://www.bionity.com/en/news/57225/novavax-names-jeffrey-church-chief-financial-officer.html